Redo surgery for noninfective isolated mitral valve disease: Initial outcome and further follow ‐up compared to primary surgery

ConclusioniMVR for noninfective reasons is infrequent and rare. Compared to primary surgery, redo's suffer mainly from bleeding-associated morbidity. This does not translate into prolonged hospital stay or inferior immediate or long-term outcomes. Redo mitral valve replacement can be performed at no significantly in creased surgical risk compared with first surgery and the results are particularly not limited by the surgery itself.

https://onlinelibrary.wiley.com/doi/10.1111/jocs.16512?af=R

Source: Journal of Cardiac Surgery - April 17, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Uwe Speiser, Daniel Pohling, Sems ‐Malte Tugtekin, Efstratios Charitos, Klaus Matschke, Manuel Wilbring Tags: ORIGINAL ARTICLE Source Type: research